Abstract
Genetically engineered mammalian cells play an essential role in many processes, from basic research to high-throughput screening and pharmaceutical protein production. In basic research, mammalian cells serve to study gene function and mechanisms of regulation. Important health-related applications include drug screening and production of secreted, pharmaceutically active proteins. The reason that mammalian cells are preferred is the close relationship to cells and their products in the human body. In particular, mammalian cells have the unique capability to authentically process, fold, and modify secreted human proteins. The resulting products are free of microbial contaminants, thereby minimizing the risk of immunogenic and inflammatory responses, respectively. In addition, human-like modifications extend the in vivo lifetime of therapeutic proteins. This translates into therapeutic products that are safe and highly active.
Keywords
- Chinese Hamster Ovary Cell
- Expression Cassette
- Internal Ribosomal Entry Site
- Recombinant Protein Production
- Bidirectional Promoter
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hauser, H. and Wagner, R., eds. (1997) Mammalian Cell Biotechnology in Protein Production, W. DeGruyter, New York, pp. 1–190.
Kozak M. (1999) Initiation of translation in prokaryotes and eukaryotes. Gene 234, 187–208.
Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547–5551.
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., and Bujard, H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766–1769.
Shockett, P. E., Difilippantonio, M., Hellman, N., and Schatz, D. G. (1995) A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. USA 92, 6522–6526.
A-Mohammadi, S. and Hawkins, R. E. (1998) Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system. Gene Ther. 5, 76–84.
Strathdee, C. A., McLeod, M. R., and Hall, J. R. (1999) Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector. Gene 229, 21–29.
Unsinger, J., Kröger, A., Hauser, H., and Wirth, D. (2001) Retroviral vectors for transduction of an autoregulated bidirectional expression cassette. Mol. Ther. 4, 484–489.
Fussenegger, M., Morris, R. P., Fux, C., Rimann, M., von Stockar, B., Thompson, C. J., et al. (2000) Streptogramin-based gene regulation systems for mammalian cells. Nat. Biotechnol. 18, 1203–1208.
Eilers, M., Picard, D., Yamamoto, K. R., and Bishop, J. (1989) Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340, 66–68.
Braselmann, S., Graninger, P., and Busslinger, M. (1993) A selective transcriptional induction system for mammalian cells based on Ga14-estrogen receptor fusion proteins. Proc. Natl. Acad. Sci. USA 90, 1657–1661.
Wang, Y., O’Malley, Jr., B. W., Tsai, S. Y., and O’Malley, B. W. (1994) Proc. Natl. Acad. Sci. USA 91, 8180–1884.
Burcin, M. M., O’Malley, B. W., and Tsai, S. Y. (1998) A regulatory system for target gene expression. Front. Biosci. 3, 1–7.
No, D., Yao, T. P., and Evans, R. M. (1996) Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93, 3346–3351.
Kaufman, R. (1990) Vectors used for expression in mammalian cells. Methods Enzymol. 185, 487–512.
Boshart, M., Weber, F., Jahn, G., Dorsch-Häsler, K., Fleckenstein, B., and Schaffner, W. (1985) A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41, 521–530.
Bell, A. C. and Felsenfeld, G. (2001) Gene regulation: insulators and boundaries: versatile regulatory elements in the eukaryotic genome. Science 291, 447–450.
Bode, J., Benham, C., Knopp, A., and Mielke, C. (2000) Transcriptional augmentation: modulation of gene expression by Scaffold/matrix attached regions (S/MAR elements). Crit. Rev. Eukaryot. Gene Expr. 10, 73–90.
Fiering, S., Whitelaw, E., and Martin, D. I. K. (2000) To be or not to be active: the stochastic nature of enhancer action. Bioessays 22, 381–387.
Ogbourne, S. and Antalis, T. M. (1998) Transcriptional control and the role of silencers in transcriptional regulation in eukaryotes. Biochem. J. 331, 1–14.
Bode, J., Schlake, M., Ríos-Ramírez, M., Mielke, C., Stengert, M., Kay, V., et al. (1995) Scaffold/matrix-attached regions: structural properties creating transcriptioally active loci, in Structural and Functional Organization of the Nuclear Matrix (International Review of Cytology). (Berezney, R. and Jeon, K. W., eds.), Academic Press, San Diego, CA, pp. 389–453.
Bell, A. C. and Felsenfeld, G. (1999) Stopped at the border: boundaries and insulators. Curr. Opin. Genet. Dev. 9, 191–198.
Li, Q. L., Harju, S., and Peterson, K. R. (1999) Locus control regions — coming of age at a decade plus. Trends Genet. 15, 403–408.
Dorner, A. J., Wasley, L. C., and Kaufman, R. J. (1989) Increased synthesis of secreted proteins induces expression of glucose- regulated proteins in butyrate-treated Chinese hamster ovary cells. J. Biol. Chem. 264, 20,602–20,607.
Kaufman, R. J., Wasley, L. C., Spiliotes, A. J., Gossels, S. D., Latt, S. A., Larsen, G. R., et al. (1985) Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells. Mol. Cell. Biol. 5, 1750–1759.
Looney, J. E. and Hamlin, J. L. (1987) Isolation of the amplified dihydrofolate reductase domain from methotrexate-resistant Chinese hamster ovary cells. Mol. Cell. Biol. 7, 569–577.
Brown, M. E., Renner, G., Field R. P., and Hassell, T. (1992) Process development for the production of recombinant antibodies using the glutamine-synthetase (GS) system. Cytotechnology 9, 231–236.
Cappechi, M. R. (1990) Gene targeting: how efficient can you get? Nature 348, 109.
Kilby, N. J., Snaith, M. R., and Murray, J. A. H. (1993) Site-specific recombinases: tools for genome engineering. Trends Genet. 9, 413–421.
Baer, A. and Bode, J. (2001) Coping with kinetic and thermodynamic barriers: RMCE, an efficient strategy for the targeted integration of transgenes. Curr. Opin. Biotechnol. 12, 473–480.
Klehr-Wirth, D., Kuhnert, F., and Hauser, H. (1997) Generation of mammalian cells with conditional expression of cre recombinase. Technical Tips online, T40067., URL: http://tto.trends.com.
Kühn, R., Rajewski, K., and Müller, W. (1995) Inducible gene targeting in mice. Science 269, 1427.
Metzger, D., Clifford, J., Chiba, H., and Chambon, P. (1995) Conditonal site-specific recombination in mamalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl. Acad. Sci. USA 92, 6991–6995.
Kellendonk, D., Tronche, F., Monaghan, A. P., Angrand, P. O., Stewart, F., and Schütz, G. (1996) Regulation of cre recombinase activity by the synthetic steroid RU486. Nucleic Acids Res. 24, 1404–1411.
Schlake, T. and Bode, J. (1994) Use of mutated Flp recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. Biochemistry 33, 12,746–12,751.
Lee, G., Kim, S., Lee, G. K. M., and Park, J. (2000) An engineered lox sequence containing part of a long terminal repeat of HIV-1 permits cre recombinase-mediated excision. Biochem. Cell Biol. 78, 653–658.
Seibler, J. and Bode, J. (1997) Double-reciprocal crossover mediated by Flp recombinase. A concept and an assay. Biochemistry 36, 1740–1747.
Seibler, J., Schübeler, D., Fiering, S., Groudine, M., and Bode, J. (1998) DNA cassette exchange in ES cells mediated by Flp recombinase: an efficient strategy for repeated modification of tagged loci by marker-free constructs. Biochemistry 37, 6229–6234.
Verhoeyen, E., Hauser, H., and Wirth, D. (1998) Efficient targeting of retrovirally FRT-tagged chromosomal loci. Techn. Tips online T01515 URL: http://tto.trends.com.
Schübeler, D., Maass, K., and Bode, J. (1998) Retargeting of retroviral integration sites for the pedictable expression of transgenes and the analysis of cis-acting sequences. Biochemistry 37, 11,907–11,914.
Verhoeyen, E., Hauser, H., and Wirth, D. (2001) Evaluation of retroviral vector design in defined chromosomal loci by Flp-mediated cassette replacement. Hum. Gene Ther. 12, 933–944.
Müller, P., Oumard, A., Wirth, D., Kröger, A., and Hauser, H. (2001) Polyvalent vectors for coexpression of multiple genes, in Plasmids for Therapy and Vaccination (Schleef, M., ed.), Wiley-VCH, Weinheim, pp. 119–136.
Martinez-Salas, E. (1999) Internal ribosome entry site biology and its use in expression vectors. Curr. Opin. Biotechnol.10, 458–464.
Jackson, R. J. and Kaminski, A. (1995) Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond. RNA 1, 985–1000.
Sachs, A. B., Sarnow, P., and Hentze, M. W. (1997) Starting at the beginning, middle, and end: translation initiation in eukaryotes. Cell 89, 831–838.
Pelletier, J. and Sonenberg, N. (1988) Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334, 320–325.
Pestova, T. V., Hellen, C. U. T., and Shatsky, I. N. (1996) Canonical eukaryotic initiation factors determine initiation of translation by internal ribosome entry. Mol. Cell. Biol. 16, 6859–6869.
Jang, S. K., Krausslich, H. G., Nicklin, M. J., Duke, G. M., Palmenberg, A. C., and Wimmer, E. (1988) A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62, 2636–2643.
Oumard, A., Hennecke, M., Hauser, H., and Nourbakhsh, M. (2000) Translation of NRF mRNA is mediated by highly efficient internal ribosome entry. Mol. Cell. Biol. 20, 2755–2759.
Chappell, S. A., Edelman, G. M., and Mauro, V. P. (2000) A 9-nt segment of a cellular mRNA can function as an internal ribosome entry site (IRES) and when present in linked multiple copies greatly enhances IRES activity. Proc. Natl. Acad. Sci. USA 97, 1536–1541.
Dirks, W., Schaper, F., Kirchhoff, S., Morelle, C., and Hauser, H. (1994) A multifunctional vector family for gene expression in mammalian cells. Gene 149, 387–388.
Dirks, W., Wirth, M., and Hauser, H. (1993) Dicistronic units for gene expression in mammalian cells. Gene 128, 247–249.
Zitvogel, L., Tahara, H., Cai, Q., Storkus, W. J., Muller, G., Wolf, S. F., et al. (1994) Construction and Characterization of retroviral vectors expressing biologically active human interleukin-12. Human Gene Ther. 5, 1493–1506.
Fussenegger, M., Mazur, X., and Bailey J. E. (1998) pTRIDENT, a novel vector family for tricistronic gene expression in mammalian cells. Biotechnol. Bioeng. 51, 1–10.
Schirmbeck, R., von Kampen, J., Metzger, K., Wild, J., Grüner, B., Schleef, M., et al. (1999) DNA-based vaccination with polycistronic expression plasmids. Methods in Molecular Medicine 29, 313–322.
Kwissa, M., Unsinger, J., Schirmbeck, R., Hauser, H., and Reimann, J. (2000) Polyvalent DNA vaccines with bidirectional promoters. J. Mol. Med. 78, 495–506.
Mielke, C., Tümmler, M, Schübeler, D., von Hoegen, I., and Hauser, H, (2000) Stabilized, long-term expression of heteromeric proteins from tricistronic mRNA. Gene 254, 1–8.
Attal, J., Theron, M. C., and Houdebine, L. M. (1999) The optimal use of IRES (internal ribosome entry site) in expression vectors, Genet. Anal. 15, 161–165.
Hennecke, M., van Kampen, J., Metzger, K., Schirmbeck, R., Reimann, J., and Hauser, H. (2001) The strength of IRES-driven translation of bicistronic expression vectors depends on the composition of the mRNA. Nucleic Acids Res. 29, 3327–3334.
Baron, U., Freundlieb, S., Gossen, M., and Bujard, H. (1995) Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res. 23, 3605–3606.
Liljestrom, P. (1994) Alphavirus expression systems. Curr. Opin. Biotechnol. 5, 495–500.
Johnston, R. E. and Peters, C. J. (1996) Alphaviruses, in Fields Virology (Fields B. N., Knipe D. M., Howley P. M., eds.), Lippincott-Raven: Philadelphia, PA, pp. 842–898.
Strauss, J. H. and Strauss, E. G. (1994) The alphavirus: gene expression, replication and evolution. Microbiol. Rev. 58, 491–562.
Pushko, P., Parker, M., Ludwig, G. V., Davis, N. L., Johnston, R. E., and Smith, J. L. (1997) Replicon helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 39, 389–401.
Berglund, P. M., Sjoberg, M., Garoff, H., Atkins, G. J., Sheahan, B. J., and Liljestrom, P. (1993) Semiliki Forest virus expression systems: production of conditionally infectious recombinant particles. Bio-technology11, 916–920.
Schlesinger, S. (1993) Alphaviruses-vectors for the expression of heterologous genes. Trends Biotechnol. 11, 18–22.
Schlesinger, S. (1995) RNA viruses as vectors for the expression of heterologous proteins. Mol. Biotechnol. 3, 155–165.
Wahlfors, J. J., Zullo, S. A., Nelson, D. M., and Morgan, R. A. (2000) Evaluation of recombinant alphaviruses as vectors in gene therapy. Gene Ther. 7, 472–480.
Herweijer, H., Latendresse, J. S., Williams, P., Zhang, G., Danko, J., Schlesinger, S., et al. (1995) A plasmid-based self amplifying [Sindbis] virus vector. Hum. Gene Ther. 6, 1161–1167.
Dubensky, T.W., Driver, D. A., Polo, J. M., Belli, B. A., Latham, E. M., Ibnaez, C. E., et al. (1996) Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J. Virol. 70, 508–519.
Perri, S., Driver, D. A., Gardner, J. P., Sherrill, S., Belli, B. A., Dubensky, T. W., et al. (2000) Replicon vectors derived from Sindbis Virus and Semliki forest virus that establish persistent replication in host cells. J. Virol. 74, 9802–9807.
Tubulekas, I., Berglund, P., Fleeton, M., and Liljeström, P. (1997) Alphavirus expression vectors and their use as recombinant vaccines: a minireview. Gene 190, 191–195.
Horwitz, M. S. (1996) Adenoviruses, in Fields Virology (Fields, B. N., Knipe, D. M., and Howley, P. M., eds.), Lippincott-Raven: Philadelphia, PA, pp. 2149–2171
Romano, G., Micheli, P., Pacilio, C., and Giordano, A. (2000) Latest developments in gene transfer technology: achievments, perspectives, and controversies over therapeutic applications. Stem Cells 18, 19–39.
Hitt, M., Bett, A. J., Prevec, L., and Graham, F. L. (1994) Construction and propagation of human adenovirus vectors, in Cell Biology: A Laboratory Handbook. Academic Press, San Diego, CA, pp. 479–490.
Kochanek, S., Clemens, P. R., Mitani, K., Chen, H. H., Chan, S., and Caskey, C. T. (1996) A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expression both full length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. USA 93, 5731–5736.
Fisher, K. J., Choi, H., Burda, J., Chen, S. J., and Wilson, J. M. (1996) Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. J. Virol. 217, 11–22.
Kitamura, T., Onishi, M., Kinoshita, S., Shibuya, A., Miyajima, A., and Nolan, G. P. (1995) Efficient screening of retroviral cDNA expression libraries. Proc. Natl. Acad. Sci. USA 92, 9146–9150.
Walther, W. and Stein, U. (2000) Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs 60, 249–271.
Cosset, F. L., Takeuchi, Y., Battini, J. L., Weiss, R. A., and Collins, M. K. (1995) High titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69, 7430–7436.
Chong, H. and Vile, R. C. (1996) Replication-competent retrovirus produced by a “splitfunction” third generation amphotropic packaging cell line. Gene Ther. 3, 624–629.
Palù, G., Parolin, C., Takeuchi, Y., and Pizzato, M. (2000) Progress with retroviral gene vectors. Rev. Med. Virol. 10, 185–202.
Emerman, M., and Temin, H. M. (1986) Comparison of a promoter suppression in avian and murine retrovirus vectors. Nucleic Acids Res. 14, 9381–9396.
Yu, S. F., von Ruden, T., Kantoff, P. W., Garber, C., Seiberg, M., Ruther, U., et al. (1995) Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Bio-technology 13, 389–392.
Bode, J., Fetzer, C. P., Nehlsen, K., Scinteie, M., Hinrichsen, B., Baiker, A., et al. (2001) The hitchhiking principle: Optimization episomal vectors for the use in gene therapy and biotechnology. Gene Ther. Mol. Biol. 6, 33–46.
Van Craenenbroeck, K., Vanhoenacker, P., Duchau, H., and Haegeman, G. (2000) Molecular integrity and usefulness of episomal expression vectors derived form BK and Epstein-Barr virus. Gene 253, 293–301.
Tan, B. T., Wu, L., and Berk, A. (1999) An Adenovirus-Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency. J. Virol. 73, 7582–7589.
Leblois, H., Roche, C., Falco, D., Orsini, P., Yeh, P., and Perricaudet, M. (2000) Stable transduction of actively dividing cells via a novel adenoviral/episomal vector. Molecular Therapy 1, 314–322.
Krougliak, V. A., Krougliak, N., and Eisensmith, R. C. (2000) Stabilization of transgenes delivered by recombinant adenovirus vectors through extrachromosomal replication. J. Gene. Med. 3, 51–58.
Feng, M., Jackson, W. H., Goldman, C. K., Rancourt, C., Wang, M., Dusing, S. K., et al. (1997) Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat. Biotechnol. 15, 866–870.
Zheng, C., Baum, B. J., Iadarola, M. J., and O’Connell, B. C. (2000) Genomic integration and gene expression by a modified adenoviral vector. Nat. Biotechnol. 18, 176–180.
Umaña, P. and Bailey, J. E. (1997) A mathematical model of N—linked glycoform biosynthesis. Biotechnol. Bioeng. 55, 890–908.
Minch, S. L., Kallio, P. T., and Bailey, J. E. (1995) Tissue plasminogen activator coexpressed in Chinese hamster ovary cells with alpha(2,6)—sialyltransferase contains NeuAc alpha(2,6) Gal beta(1,4)Glc-N-AcR linkages. Biotechnol. Prog. 11, 348–351.
Elbein, A. (1991) Glycosidase inhibitors: inhibitors of N-linked oligosaccharide processing. FASEB J. 5, 3055–3063.
Grabenhorst, E., Costa, J., and Conradt, H. S. (1997) in Animal Cell Technology (Carrondo, M. J. T., Griffiths, B., and Moreira, J. L. P., eds.), Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 481–487.
Grabenhorst, E., Hoffmann, A., Nimtz, M., Zettlmeissl, G., and Conradt, H. S. (1994) Construction of stable BHK-21 cells coexpressing human secretory glycoproteins and human Gal(beta 1–4)GlcNAc-R alpha 2,6-sialyltransferase alpha 2,6-linked NeuAc is preferentially attached to the Gal(beta 1–4)G1cNAc(beta 1–2)Man(alpha 1–3)-branch of diantennary oligosaccharides from secreted recombinant beta-trace protein. Eur. J. Biochem. 232, 718–725.
Sburlati, A., Umaña, P., Prati, E. G. P., and Bailey, J. E. (1998) Synthesis of bisected glycoforms of recombinant IFN-beta by overexpression of beta-1,4-N-acetylglucosaminyltransferase III in Chinese hamster ovary cells. Biotechnol. Prog. 14, 189–192.
Li, E., Gibson, R., and Kornfeld, S. (1980) Structure of an unusual complex-type oligosaccharide isolated from Chinese hamster ovary cells. Arch. Biochem. Biophys. 199, 393–399.
Costa, J., Grabenhorst, E., Nimtz, M., and Conradt, H. S. (1996) Stable expression of the Golgi form and secretory variants of human fucosyltransferase III from BHK-21 cells. Purification and characterization of an engineered truncated form from the culture medium. J. Biol. Chem. 272, 11,613–11,621.
Suzuki, E. and Ollis, D. F. (1990) Enhanced antibody production at slowed growth rates: experimental demonstration and a simple structured model. Biotechnol. Prog. 6, 231–236.
Franek, F. and Dolnikova, J. (1991) Hybridoma growth and monoclonal antibody production in iron-rich protein-free medium: effect of nutrient concentration. Cytotechnology 7, 33–38.
Al-Rubeai, M., Emery, A. N., Chalder, S., and Jan, D. C. (1992) Specific monoclonal antibody productivity and the cell cycle—comparisons of batch, continuous and perfusion cultures. Cytotechnology 9, 85–97.
Kirchhoff, S., Schaper, F., and Hauser, H. (1993) Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes. Nucl. Acids Res. 21, 2881–2889.
Kirchhoff, S., Koromilas, A., Schaper, F., Grashoff, M., Sonenberg, N., and Hauser, H. (1995) IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 11, 439–445.
Köster, M., Kirchhoff, S., Schaper, F., and Hauser, H. (1995) Proliferation control of mammalian cells by the tumor suppressor IRF-1. Cytotechnology 18, 67–75.
Köster, M., Kirchhoff, S., Schaper, F., and Hauser, H. (1995) Proliferation control of mammalian cells by the tumor suppressor IRF-1, in Animal Cell Technology: Developments Towards the 21st Century (Beuvery, C., Griffiths, B., and Zeijlemaker, W. P., eds.) Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 33–44
Carvalhal, A. V., Moreira, J. L., Müller, P. P., Hauser, H., and Carrondo, M. J. T. (1998) Cell growth inhibition by the IRF-1 system, in New Developments and New Applications in Animal Cell Technology (Merten, O.-W., Perrin, P, and Griffiths, B., eds.), Kluwer Academic Publishers, pp. 215–217.
Schaper, F., Kirchhoff, S., Posern, G., Köster, M., Oumard, A., Sharf, R., et al. (1998) Functional domains of Interferon Regulatory Factor 1 (IRF-1). Biochemical J. 335, 147–157.
Kirchhoff, S., Wilhelm, D., Angel, P., and Hauser, H. (1999) NFKB activation is required for IRF-1 mediated IFN-β. Eur. J. Biochem. 261, 546–554.
Kirchhoff, S., Oumard, A., Nourbakhsh, M., Levi, B.-Z., and Hauser, H. (2000) Interplay between repressing and activating domains defines the transcriptional activity of IRF-1. Eur. J. Biochem. 267, 6753–6761.
Müller, P. P., Carvalhal, A. V., Moreira, J. L., Geserick, C., Schroeder, K., Carrondo, M. J. T., et al. (1999) Development of an IRF-1-based proliferation control system, in Cell Engineering 1 (Al-Rubeai, M., Betenbaugh, M., Hauser, H., Jenkins, N., MacDonald, C., Merten, A.-W., eds.), Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 220–238.
Kröger, A., Köster, M., Schroeder, K., Hauser, H., and Mueller, P. P. (2002) Activities of IRF-1. J. Interferon and Cytokine Res. 22, 5–14.
Geserick, C., Bonarius, H. P. J., Kongerslev, L., Hauser, H., and Müller, P. P. (2000) Enhanced productivity during controlled proliferation of BHK cells in continuously perfused bioreactors. Biotech. Bioeng. 69, 266–274.
Müller, P. P., Kirchhoff, S., and Hauser, H. (1998) Sustained expression in proliferation controlled BHK-21 cells, in New developments and new applications in animal cell technology (Merten, O.-W., Perrin, P, and Griffiths, B., eds.), Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 209–214.
Kirchhoff, S., Kröger, A., Cruz, H., Tümmler, M., Schaper, F., Köster, M., et al. (1996) Regulation of cell growth by IRF-1 in BHK-21 cells. Cytotechnology 22, 147–156.
Geserick, C., Schroeder, K., Bonarius, H., Kongerslev, L., Schlenke, P., Hauser, H., et al. (1999) Recombinant pharmaceutical protein overexpression in an IRF-1 proliferation controlled production system, in Animal Cell Technology: Products from Cells, Cells as Products (Bernard, A., Griffiths, B., Nod, W., and Wurm, F. eds.), Kluwer Academic Publishers, The Netherlands, pp. 3–10.
Carvalhal, A. V., Moreira, J. L., Cruz, H., Mueller, P. P., Hauser, H., and Carrondo, M. J. T. (2000) Manipulation of culture conditions for BHK cell growth inhibition by IRF-1 activation. Cytotechnology 32, 135–145.
Müller, P. P., Grabenhorst, E., Conradt, H. S., and Hauser, H. (1999) Recombinant glycoprotein product quality in proliferation controlled BHK-21 cells. Biotechnol. Bioeng. 65, 529–536.
Schroeder, K., Koschmieder, S., Ottmann, O. G., Hoelzer, D., Hauser, H., and Mueller, P. P. (2002) Genetic proliferation control facilitates the handling of a human stromal feeder cell line during coccultivation with hematopoietic progenitor cells. Biotechnol. Bioeng. 78, 346–352.
Fussenegger, M., Schlatter, S., Dätwyler, D., Mazur, X., and Bailey, J. E. (1998) Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat. Biotechnol. 16, 468–472.
Fussenegger, M. and Bailey, J. E. (1998) Molecular regulation of cell-cycle progression and apoptosis in mammalian cells: implication for biotechnology. Biotechnol. Prog. 14, 807–833.
Mercille, S. and Massie, B. (1999) Apoptosis-resistant E1B-19K-expressing NS/0 myeloma cells exhibit increased viability and chimeric antibody productivity under perfusion culture conditions. Biotechnol. Bioeng. 63, 529–543.
Cotter, T. G. and Al-Rubeai, M (1995) Cell death (apoptosis) in cell culture systems. Trends Biotechnol. 13, 150–155.
Perreault, J. and Lemieux, R. (1993) Essential role of optimal protein synthesis in preventing the apoptotic death of cultured B cell hybridomas. Cytotechnology 13, 99–105.
Singh, R. P., Emery, A. N., and Al-Rubeai, M. (1996) Enhancement of survivability of mammalian cells by overexpression of the apoptosis-suppressor gene bcl-2. Biotechnol. Bioeng. 52, 166–175.
Chung, J. D., Sinskey, A. J., and Stephanopoulos, G. (1998) Growth factor and bcl-2 mediated survival during abortive proliferation of hybridoma cell line. Biotechnol. Bioeng. 57, 164–171.
Simpson, N. H., Milner, A. E., and Al-Rubeai, M. (1997) Prevention of hybridoma cell death by bcl-2 during suboptimal culture conditions. Biotechnol. Bioeng. 54, 1–16.
Huang, D. C. S., Cory, S., and Strasser, A. (1997) Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 14, 405–414.
Terada, S., et al. (1997) Anti-apoptotic genes, bag-1 and bc1–2, enabled hybridoma cells to survive under treatment for arresting cell cycle. Cytotechnology 25, 17–23.
Zanghi, J. A., Fussenegger, M., and Bailey, J. E. (1999) Serum protects protein—free competent Chinese hanster ovary cells against apoptosis induced by nutrient deprivation in batch culture. Biotechnol. Bioeng. 5, 573–582.
Mastrangelo, A. J., Hardwick, M. J., Zou, S., and Betenbaugh, M. J. (2000) Part 2. Overexpression of bc1–2 family members enhances survival of mammalian cells in response to various culture insults. Biotechnol. Bioeng. 67, 555–564.
Vives, J., Juanola, S., Gabernet, C., Prats, E., Cairo, J. J., Cornudella, L., et al. (2001) Genetic strategies for apoptosis protection and hybridoma cells based on overexpression of cellular and viral proteins, in Animal Cell Technology: From Target to Market (Lindner-Olsson, E., et al., eds.), Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 230–233.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mueller, P.P., Wirth, D., Unsinger, J., Hauser, H. (2003). Genetic Approaches to Recombinant Protein Production in Mammalian Cells. In: Vinci, V.A., Parekh, S.R. (eds) Handbook of Industrial Cell Culture. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-346-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-59259-346-0_2
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-315-2
Online ISBN: 978-1-59259-346-0
eBook Packages: Springer Book Archive